Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Ria

Showing results (81-90 of 137) with videos related to

Pageof 14
Sort By:
Oncoimmunology|December 15, 2018
Bone marrow endothelial cells sustain a tumor-specific CD8<sup>+</sup> T cell subset with suppressive function in myeloma patientsPatrizia Leone, Giuseppe Di Lernia, Antonio Giovanni Solimando, et al.
Surgery|June 3, 2020
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?Roberto Ria, Francesco Prete, Assunta Melaccio, et al.
Oncotarget|May 15, 2018
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myelomaAurelia Lamanuzzi, Ilaria Saltarella, Vanessa Desantis, et al.
Clinical and Experimental Medicine|February 24, 2023
STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failureAntonio Giovanni Solimando, Vanessa Desantis, Carmen Palumbo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 8, 2024
Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4-1BB: A preclinical study in multiple myelomaIlaria Saltarella, Alexander Link, Aurelia Lamanuzzi, et al.
Haematologica|April 6, 2019
Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myelomaLaura Mazzera, Manuela Abeltino, Guerino Lombardi, et al.
Blood Advances|September 9, 2025
Progressive NK-cell dysfunction and ILC imbalance favor immune evasion in multiple myelomaMaria Teresa Bilotta, Antonio Giovanni Solimando, Vanessa Desantis, et al.
Blood|July 12, 2003
Endothelial cells in the bone marrow of patients with multiple myelomaAngelo Vacca, Roberto Ria, Fabrizio Semeraro, et al.
Experimental Hematology & Oncology|August 6, 2024
Measurable therapeutic antibody in serum as potential predictive factor of response to anti-CD38 therapy in non-IgG-k myeloma patientsEmilia Gigliotta, Federica Plano, Giusy Corsale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2009
Gene expression profiling of bone marrow endothelial cells in patients with multiple myelomaRoberto Ria, Katia Todoerti, Simona Berardi, et al.
Pageof 14

Showing results (81-90 of 137) with videos related to

Sort By:
Pageof 14
Oncoimmunology|December 15, 2018
Bone marrow endothelial cells sustain a tumor-specific CD8<sup>+</sup> T cell subset with suppressive function in myeloma patientsPatrizia Leone, Giuseppe Di Lernia, Antonio Giovanni Solimando, et al.
Surgery|June 3, 2020
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?Roberto Ria, Francesco Prete, Assunta Melaccio, et al.
Oncotarget|May 15, 2018
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myelomaAurelia Lamanuzzi, Ilaria Saltarella, Vanessa Desantis, et al.
Clinical and Experimental Medicine|February 24, 2023
STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failureAntonio Giovanni Solimando, Vanessa Desantis, Carmen Palumbo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 8, 2024
Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4-1BB: A preclinical study in multiple myelomaIlaria Saltarella, Alexander Link, Aurelia Lamanuzzi, et al.
Haematologica|April 6, 2019
Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myelomaLaura Mazzera, Manuela Abeltino, Guerino Lombardi, et al.
Blood Advances|September 9, 2025
Progressive NK-cell dysfunction and ILC imbalance favor immune evasion in multiple myelomaMaria Teresa Bilotta, Antonio Giovanni Solimando, Vanessa Desantis, et al.
Blood|July 12, 2003
Endothelial cells in the bone marrow of patients with multiple myelomaAngelo Vacca, Roberto Ria, Fabrizio Semeraro, et al.
Experimental Hematology & Oncology|August 6, 2024
Measurable therapeutic antibody in serum as potential predictive factor of response to anti-CD38 therapy in non-IgG-k myeloma patientsEmilia Gigliotta, Federica Plano, Giusy Corsale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2009
Gene expression profiling of bone marrow endothelial cells in patients with multiple myelomaRoberto Ria, Katia Todoerti, Simona Berardi, et al.
Pageof 14